Dimensional Fund Advisors
KYMR icon

Dimensional Fund Advisors’s Kymera Therapeutics KYMR Stock Holding History

Dimensional Fund Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$77.5M Sell
693,290
-51,862
-7% -$5.94M 0.01% 1333
2026
Q2 		$85.4M Buy
745,152
+152,273
+26% +$13.1M 0.02% 1298
2026
Q1 		$49.4M Sell
592,879
-31,148
-5% -$2.47M 0.01% 1504
2025
Q4 		$48.6M Sell
624,027
-107,393
-15% -$7.25M 0.01% 1524
2025
Q3 		$41.4M Buy
731,420
+168,055
+30% +$7.58M 0.01% 1621
2025
Q2 		$24.6M Buy
563,365
+167,897
+42% +$5.78M 0.01% 1871
2025
Q1 		$10.8M Sell
395,468
-38,287
-9% -$1.4M ﹤0.01% 2218
2024
Q4 		$17.4M Sell
433,755
-38,871
-8% -$1.76M ﹤0.01% 2051
2024
Q3 		$22.4M Buy
472,626
+70,241
+17% +$3.1M 0.01% 1953
2024
Q2 		$12M Buy
402,385
+53,176
+15% +$1.84M ﹤0.01% 2182
2024
Q1 		$14M Sell
349,209
-184,514
-35% -$6.6M ﹤0.01% 2165
2023
Q4 		$13.6M Sell
533,723
-121,504
-19% -$2.17M ﹤0.01% 2179
2023
Q3 		$9.11M Sell
655,227
-185,711
-22% -$3.73M ﹤0.01% 2312
2023
Q2 		$19.3M Buy
840,938
+100,947
+14% +$2.89M 0.01% 1949
2023
Q1 		$21.9M Buy
+739,991
New +$23.9M 0.01% 1854
2022
Q3 		$4.62M Buy
212,365
+25,084
+13% +$661K ﹤0.01% 2452
2022
Q2 		$3.69M Sell
187,281
-50,450
-21% -$1.18M ﹤0.01% 2544
2022
Q1 		$10.1M Buy
237,731
+172,839
+266% +$7.3M ﹤0.01% 2298
2021
Q4 		$4.12M Buy
+64,892
New +$3.78M ﹤0.01% 2626

Other funds holding KYMR

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Kornitzer Capital Management
Kornitzer Capital Management Shawnee Mission, Kansas $4.8B AUM 30.14% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.2B AUM 30.02% 1-Year Est. Return

Dimensional Fund Advisors's KYMR Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Kymera Therapeutics (KYMR) stake by 7% in Q3 2026, selling an estimated $5.94M and leaving 693,290 shares worth $77.5M. The position accounts for 0.01% of the portfolio, ranked #1333.

Dimensional Fund Advisors first reported a position in KYMR in Q4 2021 and has held it in 19 quarters since. The position peaked at $85.4M in Q2 2026. 81 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Dimensional Fund Advisors held 693,290 shares of Kymera Therapeutics worth $77.5M as of Q3 2026.
  • Dimensional Fund Advisors sold 51,862 Kymera Therapeutics shares in Q3 2026, an estimated $5.94M.
  • Kymera Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #1333 holding.
  • Dimensional Fund Advisors first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Dimensional Fund Advisors's Kymera Therapeutics position peaked at $85.4M in Q2 2026.
  • 81 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.